Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2011

01-04-2011 | Original Article

5-Aminosalicylic Acid (5-ASA) Can Reduce Levels of Oxidative DNA Damage in Cells of Colonic Mucosa With and Without Fecal Stream

Authors: Caroline Caltabiano, Felipe Rodrigues Máximo, Ana Paula Pimentel Spadari, Daniel Duarte da Conceição Miranda, Marcia Milena Pivatto Serra, Marcelo Lima Ribeiro, Carlos Augusto Real Martinez

Published in: Digestive Diseases and Sciences | Issue 4/2011

Login to get access

Abstract

Background

No studies have evaluated the effectiveness of 5-ASA against oxidative DNA damage in experimental models of diversion colitis.

Aim

To evaluate the effects of 5-ASA against oxidative DNA damage in an experimental model of diversion colitis.

Methods

Twenty-six Wistar rats were divided into two groups corresponding to sacrifice at 2 or 4 weeks after fecal diversion of the left colon by means of proximal colostomy and distal mucosa fistula. Each group was divided into two subgroups according to intervention in excluded colon performed with 0.9% saline solution or 5-ASA. Level of oxidative DNA damage was determined by comet assay in cells obtained from segments with and without fecal stream before and after H2O2 challenge. For statistical analysis, was used one-way analysis of variance (ANOVA), adopting a 5% significance level (P < 0.05).

Results

Levels of DNA damage were always higher in colon segments without fecal stream, regardless of the intervention solution employed. DNA damage in colon segments with and without fecal stream in animals irrigated with 5-ASA was lower when compared with those treated with saline solution, regardless of time of irrigation. These levels remained lower after intervention with 5-ASA, even after H2O2 challenge.

Conclusions

Enema with 5-ASA reduces oxidative DNA damage in epithelial cells of colon segments without fecal stream, even after H2O2 challenge, confirming the effects of 5-ASA against DNA damage by oxygen free radicals.
Literature
1.
go back to reference Glotzer DJ, Glick ME, Goldman H. Proctitis and colitis following diversion of fecal stream. Gastroenterology. 1981;80:438–441.PubMed Glotzer DJ, Glick ME, Goldman H. Proctitis and colitis following diversion of fecal stream. Gastroenterology. 1981;80:438–441.PubMed
2.
3.
go back to reference Geraghty JM, Talbot IC. Diversion colitis: histological features in the colon and rectum after defunctioning colostomy. Gut. 1991;32:1020–1023.PubMedCrossRef Geraghty JM, Talbot IC. Diversion colitis: histological features in the colon and rectum after defunctioning colostomy. Gut. 1991;32:1020–1023.PubMedCrossRef
4.
go back to reference Lavoine E, Vissuzaine C, Cadiot G, et al. Proctitis of diversion on an excluded rectum in patients with hemorrhagic rectocolitis. Gastroenterol Clin Biol. 1996;20:243–247.PubMed Lavoine E, Vissuzaine C, Cadiot G, et al. Proctitis of diversion on an excluded rectum in patients with hemorrhagic rectocolitis. Gastroenterol Clin Biol. 1996;20:243–247.PubMed
5.
go back to reference Haas PA, Haas GP. A critical evaluation of the Hartmann’s procedure. Am Sur. 1988;54:380–385. Haas PA, Haas GP. A critical evaluation of the Hartmann’s procedure. Am Sur. 1988;54:380–385.
6.
go back to reference Keli E, Bouchoucha M, Devroede G, et al. Diversion-related experimental colitis in rats. Dis Colon Rectum. 1997;40:222–228.PubMedCrossRef Keli E, Bouchoucha M, Devroede G, et al. Diversion-related experimental colitis in rats. Dis Colon Rectum. 1997;40:222–228.PubMedCrossRef
7.
go back to reference Frisbie JH, Ahmed N, Hirano I, et al. Diversion colitis in patients with myelopathy: clinical, endoscopic, and histopathological findings. J Spinal Cord Med. 2000;23:142–149.PubMed Frisbie JH, Ahmed N, Hirano I, et al. Diversion colitis in patients with myelopathy: clinical, endoscopic, and histopathological findings. J Spinal Cord Med. 2000;23:142–149.PubMed
8.
go back to reference Bax TW, McNevin MS. The value of diverting loop ileostomy on the high-risk colon and rectal anastomosis. Am J Surg. 2007;193:585–587.PubMedCrossRef Bax TW, McNevin MS. The value of diverting loop ileostomy on the high-risk colon and rectal anastomosis. Am J Surg. 2007;193:585–587.PubMedCrossRef
9.
go back to reference Koutroubakis IE. Spectrum of non-inflammatory bowel disease and non-infectious colitis. World J Gastroenterol. 2008;14:7277–7279.PubMedCrossRef Koutroubakis IE. Spectrum of non-inflammatory bowel disease and non-infectious colitis. World J Gastroenterol. 2008;14:7277–7279.PubMedCrossRef
10.
go back to reference Habr-Gama A, Teixeira MG, Vieira MJF, et al. Operaçäo de Hartmann e suas conseqüências. Rev Bras Coloproctol. 1997;17:5–10. Habr-Gama A, Teixeira MG, Vieira MJF, et al. Operaçäo de Hartmann e suas conseqüências. Rev Bras Coloproctol. 1997;17:5–10.
11.
go back to reference David GG, Al-Sarira AA, Willmott S, et al. Use of Hartmann’s procedure in England. Colorectal Dis. 2009;11:308–312.PubMedCrossRef David GG, Al-Sarira AA, Willmott S, et al. Use of Hartmann’s procedure in England. Colorectal Dis. 2009;11:308–312.PubMedCrossRef
12.
go back to reference Curi A, Mascarenhas JCS, Moreira Junior H, et al. Morbimortalidade associada à reconstrução do trânsito intestinal—Análise de 67 casos. Rev Bras Coloproct. 2002;22:88–97. Curi A, Mascarenhas JCS, Moreira Junior H, et al. Morbimortalidade associada à reconstrução do trânsito intestinal—Análise de 67 casos. Rev Bras Coloproct. 2002;22:88–97.
13.
go back to reference Neut C, Guillemot F, Colombel JF. Nitrate-reducing bacteria in diversion colitis: a clue to inflammation? Dig Dis Sci. 1997;42:2577–2580.PubMedCrossRef Neut C, Guillemot F, Colombel JF. Nitrate-reducing bacteria in diversion colitis: a clue to inflammation? Dig Dis Sci. 1997;42:2577–2580.PubMedCrossRef
14.
go back to reference Villanacci V, Talbot IC, Rossi E, et al. Ischaemia: a pathogenetic clue in diversion colitis? Colorectal Dis. 2007;9:601–605.PubMedCrossRef Villanacci V, Talbot IC, Rossi E, et al. Ischaemia: a pathogenetic clue in diversion colitis? Colorectal Dis. 2007;9:601–605.PubMedCrossRef
15.
go back to reference Roediger WE, Rae DA. Trophic effect of short chain fatty acids on mucosal handling of ions by the defunctioned colon. Br J Surg. 1982;69:23–25.PubMedCrossRef Roediger WE, Rae DA. Trophic effect of short chain fatty acids on mucosal handling of ions by the defunctioned colon. Br J Surg. 1982;69:23–25.PubMedCrossRef
16.
go back to reference Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23–28.PubMedCrossRef Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23–28.PubMedCrossRef
17.
go back to reference Neut C, Guillemot F, Gower-Rousseau C, et al. Treatment of diversion colitis with shorty-chain fatty acids. Bacteriological study. Gastroenterol Clin Biol. 1995;19:871–875.PubMed Neut C, Guillemot F, Gower-Rousseau C, et al. Treatment of diversion colitis with shorty-chain fatty acids. Bacteriological study. Gastroenterol Clin Biol. 1995;19:871–875.PubMed
18.
go back to reference Christl SU, Eisner HD, Dusel G, et al. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci. 1996;41:2477–2481.PubMedCrossRef Christl SU, Eisner HD, Dusel G, et al. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci. 1996;41:2477–2481.PubMedCrossRef
19.
go back to reference Oliveira-Neto JP, Aguilar-Nascimento JE. Intraluminal irrigations with fibers improves mucosal inflammation and atrophy in diversion colitis. Nutrition. 2004;20:197–199.PubMedCrossRef Oliveira-Neto JP, Aguilar-Nascimento JE. Intraluminal irrigations with fibers improves mucosal inflammation and atrophy in diversion colitis. Nutrition. 2004;20:197–199.PubMedCrossRef
20.
go back to reference Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7:563–567.PubMedCrossRef Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7:563–567.PubMedCrossRef
21.
go back to reference Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.PubMedCrossRef Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol. 2006;40:235–243.PubMedCrossRef
22.
go back to reference Fillmann H, Kretzmann NA, San-Miguel B, et al. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology. 2007;236:217–226.PubMedCrossRef Fillmann H, Kretzmann NA, San-Miguel B, et al. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology. 2007;236:217–226.PubMedCrossRef
23.
go back to reference Nassri CGG, Nassri AB, Favero E, et al. Influência da irrigação de soluções nutricionais no colo excluso de trânsito intestinal. Estudo experimental em ratos. Rev Bras Coloproct. 2008;28:306–314. Nassri CGG, Nassri AB, Favero E, et al. Influência da irrigação de soluções nutricionais no colo excluso de trânsito intestinal. Estudo experimental em ratos. Rev Bras Coloproct. 2008;28:306–314.
24.
go back to reference Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15:79–94.PubMedCrossRef Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15:79–94.PubMedCrossRef
25.
go back to reference Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol. 2005;11:2371–2384.PubMed Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol. 2005;11:2371–2384.PubMed
26.
go back to reference Nieto N, Torres MI, Ríos A, et al. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr. 2002;132:11–19.PubMed Nieto N, Torres MI, Ríos A, et al. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr. 2002;132:11–19.PubMed
27.
go back to reference Roediger WE, Truelove SC. Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979;20:484–488.PubMedCrossRef Roediger WE, Truelove SC. Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979;20:484–488.PubMedCrossRef
28.
go back to reference Roediger WE. The starved colon—diminished mucosal nutrition, diminished absorption, and colitis. Dis Colon Rectum. 1990;33:858–862.PubMedCrossRef Roediger WE. The starved colon—diminished mucosal nutrition, diminished absorption, and colitis. Dis Colon Rectum. 1990;33:858–862.PubMedCrossRef
29.
go back to reference Liu Q, Shimoyama T, Suzuki K, et al. Effect of sodium butyrate on reactive oxygen species generation by human neutrophils. Scand J Gastroenterol. 2001;36:744–750.PubMedCrossRef Liu Q, Shimoyama T, Suzuki K, et al. Effect of sodium butyrate on reactive oxygen species generation by human neutrophils. Scand J Gastroenterol. 2001;36:744–750.PubMedCrossRef
30.
go back to reference Rosignoli P, Fabiani R, De Bartolomeu A, et al. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis. 2001;22:1675–1680.PubMedCrossRef Rosignoli P, Fabiani R, De Bartolomeu A, et al. Protective activity of butyrate on hydrogen peroxide-induced DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis. 2001;22:1675–1680.PubMedCrossRef
31.
go back to reference Halliwell B, Gutteridge JM. Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J Neurochem. 1997;69:1330–1331.PubMedCrossRef Halliwell B, Gutteridge JM. Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J Neurochem. 1997;69:1330–1331.PubMedCrossRef
32.
go back to reference Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med. 2000;29:222–230.PubMedCrossRef Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Rad Biol Med. 2000;29:222–230.PubMedCrossRef
33.
go back to reference Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci. 2000;899:136–147.PubMedCrossRef Gutteridge JM, Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci. 2000;899:136–147.PubMedCrossRef
34.
go back to reference Møller P. The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures. Basic Clin Pharmacol Toxicol. 2006;98:336–345.PubMedCrossRef Møller P. The alkaline comet assay: towards validation in biomonitoring of DNA damaging exposures. Basic Clin Pharmacol Toxicol. 2006;98:336–345.PubMedCrossRef
35.
go back to reference Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996;216:132–148.PubMedCrossRef Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996;216:132–148.PubMedCrossRef
36.
37.
go back to reference Riedle B, Kerjaschki D. Reactive oxygen species cause direct damage of Englebreth-Holm-Swarm matrix. Am J Pathol. 1997;151:215–231.PubMed Riedle B, Kerjaschki D. Reactive oxygen species cause direct damage of Englebreth-Holm-Swarm matrix. Am J Pathol. 1997;151:215–231.PubMed
38.
go back to reference Martinez CA, Bartocci PC, do Carmo CV, Pereira JA, Miranda DD, Ribeiro ML. The effects of oxidative DNA damage and mutations in the p53 protein on cells of the colonic mucosa with and without the fecal stream: an experimental study in rats. Scand J Gastroenterol. 2010;45:714–724.PubMedCrossRef Martinez CA, Bartocci PC, do Carmo CV, Pereira JA, Miranda DD, Ribeiro ML. The effects of oxidative DNA damage and mutations in the p53 protein on cells of the colonic mucosa with and without the fecal stream: an experimental study in rats. Scand J Gastroenterol. 2010;45:714–724.PubMedCrossRef
39.
go back to reference Longatti TS, Acedo SC, de Oliveira CC, et al. Inflammatory alterations in excluded colon in rats—a comparison with chemically-induced colitis. Scand J Gastroenterol. 2010;45:315–324.PubMedCrossRef Longatti TS, Acedo SC, de Oliveira CC, et al. Inflammatory alterations in excluded colon in rats—a comparison with chemically-induced colitis. Scand J Gastroenterol. 2010;45:315–324.PubMedCrossRef
40.
go back to reference Triantafillidis JK, Nicolakis D, Mountaneas G, et al. Treatment of diversion colitis with 5-aminosalicylic acid enemas: comparison with betamethasone enemas. Am J Gastroenterol. 1991;86:1552–1553.PubMed Triantafillidis JK, Nicolakis D, Mountaneas G, et al. Treatment of diversion colitis with 5-aminosalicylic acid enemas: comparison with betamethasone enemas. Am J Gastroenterol. 1991;86:1552–1553.PubMed
41.
go back to reference Tripodi J, Gorcey S, Burakoff R. A case of diversion colitis treated with 5-aminosalicylic acid enemas. Am J Gastroenterol. 1992;87:645–647.PubMed Tripodi J, Gorcey S, Burakoff R. A case of diversion colitis treated with 5-aminosalicylic acid enemas. Am J Gastroenterol. 1992;87:645–647.PubMed
42.
go back to reference Song M, Xia B, Li J. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgraduat Med J. 2006;82:130–135.CrossRef Song M, Xia B, Li J. Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats. Postgraduat Med J. 2006;82:130–135.CrossRef
43.
go back to reference Ancha HR, Kurella RR, McKimmey CC, et al. Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats. Exp Biol Med (Maywood). 2008;233:1301–1308.CrossRef Ancha HR, Kurella RR, McKimmey CC, et al. Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats. Exp Biol Med (Maywood). 2008;233:1301–1308.CrossRef
44.
go back to reference Ancha HR, Kurella RR, McKimmey CC, et al. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci. 2009;54:758–766.PubMedCrossRef Ancha HR, Kurella RR, McKimmey CC, et al. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci. 2009;54:758–766.PubMedCrossRef
45.
go back to reference Cortot A, Maetz D, Degoutte E, et al. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Am J Gastroenterol. 2008;103:3106–3114.PubMedCrossRef Cortot A, Maetz D, Degoutte E, et al. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Am J Gastroenterol. 2008;103:3106–3114.PubMedCrossRef
46.
go back to reference Singh NP, McCoy MT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184–191.PubMedCrossRef Singh NP, McCoy MT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175:184–191.PubMedCrossRef
47.
go back to reference Agarwal VP, Schimmel EM. Diversion colitis: a nutritional deficiency syndrome? Nutr Rev. 1989;47:257–261.PubMedCrossRef Agarwal VP, Schimmel EM. Diversion colitis: a nutritional deficiency syndrome? Nutr Rev. 1989;47:257–261.PubMedCrossRef
48.
go back to reference Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut. 1990;31:786–790.PubMedCrossRef Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut. 1990;31:786–790.PubMedCrossRef
49.
go back to reference Sousa MV, Priolli DG, Portes AV, et al. Evaluation by computerized morphometry of histopathological alterations of the colon wall in segments with and without intestinal transit in rats. Acta Cir Bras. 2008;23:417–424.PubMedCrossRef Sousa MV, Priolli DG, Portes AV, et al. Evaluation by computerized morphometry of histopathological alterations of the colon wall in segments with and without intestinal transit in rats. Acta Cir Bras. 2008;23:417–424.PubMedCrossRef
50.
go back to reference Nonose R, Spadari APP, Priolli DG, et al. Tissue quantification of neutral and acid mucins in the mucosa of the colon with and without fecal stream: experimental study in rats. Acta Cir Bras. 2009;24:267–275.PubMedCrossRef Nonose R, Spadari APP, Priolli DG, et al. Tissue quantification of neutral and acid mucins in the mucosa of the colon with and without fecal stream: experimental study in rats. Acta Cir Bras. 2009;24:267–275.PubMedCrossRef
51.
go back to reference Miyashi Y, Yoshioka A, Iamamura S, et al. Effect of sulphasalazine and its metebolites on the generation of reactive oxygen species. Gut. 1987;28:190–195.CrossRef Miyashi Y, Yoshioka A, Iamamura S, et al. Effect of sulphasalazine and its metebolites on the generation of reactive oxygen species. Gut. 1987;28:190–195.CrossRef
52.
go back to reference Conner E, Brand S, Davis J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis. 1996;2:133–147.CrossRef Conner E, Brand S, Davis J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease: toxins, mediators, and modulators of gene expression. Inflamm Bowel Dis. 1996;2:133–147.CrossRef
53.
go back to reference Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr. 2007;41:18–26.PubMedCrossRef Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr. 2007;41:18–26.PubMedCrossRef
54.
go back to reference Simmonds NJ, Allen RE, Stevens TRJ, et al. Chemiluminescence assay of mucosal reactive metabolities in inflammatory bowel disease. Gastroenterology. 1992;103:186–196.PubMed Simmonds NJ, Allen RE, Stevens TRJ, et al. Chemiluminescence assay of mucosal reactive metabolities in inflammatory bowel disease. Gastroenterology. 1992;103:186–196.PubMed
55.
go back to reference Millar AD, Rampton DS, Chander CL, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 1996;39:407–415.PubMedCrossRef Millar AD, Rampton DS, Chander CL, et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 1996;39:407–415.PubMedCrossRef
56.
go back to reference Guijarro LG, Mate J, Gisbert JP, et al. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol. 2008;14:2851–2857.PubMedCrossRef Guijarro LG, Mate J, Gisbert JP, et al. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol. 2008;14:2851–2857.PubMedCrossRef
57.
go back to reference Nikfar S, Rahimi R, Rezaie A, et al. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci. 2009;54:1157–1170.PubMedCrossRef Nikfar S, Rahimi R, Rezaie A, et al. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci. 2009;54:1157–1170.PubMedCrossRef
58.
go back to reference Ikeda I, Ominoto A, Wada K, et al. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model. Clin Cancer Res. 2007;13:6527–6531.PubMedCrossRef Ikeda I, Ominoto A, Wada K, et al. 5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model. Clin Cancer Res. 2007;13:6527–6531.PubMedCrossRef
59.
go back to reference Ribeiro ML, Priolli DG, Miranda DDC, et al. Analysis of oxidative DNA damage in patients with colorectal cancer. Clin Colorectal Cancer. 2008;7:267–272.PubMedCrossRef Ribeiro ML, Priolli DG, Miranda DDC, et al. Analysis of oxidative DNA damage in patients with colorectal cancer. Clin Colorectal Cancer. 2008;7:267–272.PubMedCrossRef
60.
go back to reference Siddiqui A, Ancha H, Tedesco D, et al. Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis. Dig Dis Sci. 2006;51:698–705.PubMedCrossRef Siddiqui A, Ancha H, Tedesco D, et al. Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis. Dig Dis Sci. 2006;51:698–705.PubMedCrossRef
61.
go back to reference Aslan A, Temiz M, Atik E, et al. Effectiveness of mesalamine and propolis in experimental colitis. Adv Ther. 2007;24:1085–1097.PubMedCrossRef Aslan A, Temiz M, Atik E, et al. Effectiveness of mesalamine and propolis in experimental colitis. Adv Ther. 2007;24:1085–1097.PubMedCrossRef
62.
go back to reference dos Reis SB, de Oliveira CC, Acedo SC, et al. Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytother Res. 2009;23:324–329.PubMedCrossRef dos Reis SB, de Oliveira CC, Acedo SC, et al. Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytother Res. 2009;23:324–329.PubMedCrossRef
63.
go back to reference Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24:353–362.PubMedCrossRef Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003;24:353–362.PubMedCrossRef
64.
go back to reference Wentzel JF, Gouws C, Huysamen C, DyK EV, Koekemoer G, Pretorius PJ. Assessing the DNA methylation status of single cells with comet assay. Anal Biochem. 2010 Feb 13 [Epub ahead of print]. Wentzel JF, Gouws C, Huysamen C, DyK EV, Koekemoer G, Pretorius PJ. Assessing the DNA methylation status of single cells with comet assay. Anal Biochem. 2010 Feb 13 [Epub ahead of print].
65.
go back to reference Naganuma M, Iwao Y, Ogata H, et al. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine. Inflamm Bowel Dis. 2001;7:221–225.PubMedCrossRef Naganuma M, Iwao Y, Ogata H, et al. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine. Inflamm Bowel Dis. 2001;7:221–225.PubMedCrossRef
66.
go back to reference Lakatos PL, Lakatos L. Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opin Pharmacother. 2008;9:741–749.PubMedCrossRef Lakatos PL, Lakatos L. Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opin Pharmacother. 2008;9:741–749.PubMedCrossRef
67.
go back to reference Marshall JK, Irvine EJ. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol. 2000;95:1628–1636.PubMedCrossRef Marshall JK, Irvine EJ. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol. 2000;95:1628–1636.PubMedCrossRef
Metadata
Title
5-Aminosalicylic Acid (5-ASA) Can Reduce Levels of Oxidative DNA Damage in Cells of Colonic Mucosa With and Without Fecal Stream
Authors
Caroline Caltabiano
Felipe Rodrigues Máximo
Ana Paula Pimentel Spadari
Daniel Duarte da Conceição Miranda
Marcia Milena Pivatto Serra
Marcelo Lima Ribeiro
Carlos Augusto Real Martinez
Publication date
01-04-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1378-z

Other articles of this Issue 4/2011

Digestive Diseases and Sciences 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.